Go to the id21 home page   ID21 - communicating development research
Health
 
Search the whole id21 database
 

Help page and other search methods
    id21 Health
  Health systems
and economics
  Non-communicable
diseases
  Infectious
diseases
  HIV/AIDS
  Sexual and
reproductive health
  Maternal health
  Child health
  Environmental
health
 
    id21 Global Issues
 
    id21 Education
 
    id21 Urban Development
 
    id21 Natural Resources
 
    id21 Rural Development
 
    id21 Home page
 
    Gender and Violence in African Schools
 
    id21 Publications
 
    id21 Viewpoints
 
    About id21
 
    Links
 
    Contact id21
 
    id21News
 
    id21 Insights
 
    id21 Media
 
     
A decade on: what is the impact of China’s TB programme?

550 million Chinese people are infected with tuberculosis (TB). About ten percent of them may go on to develop TB disease, which kills 130,000 people annually. In 1991 the National TB Control Programme launched a ten year strategy to tackle this huge problem. How effective has it been and what are the challenges for the future?

Research by the Liverpool School of Tropical Medicine used published and unpublished data and personal communications with TB professionals in China to address this and other questions.

Although effective measures can stop infected people from developing active disease, these are not practical for such a huge number of people. So treating infectious TB patients is seen as the most effective way to control TB in China. The TB programme, which includes implementation of the World Health Organisation's DOTS strategy, increased the cure rate to more than 90 percent for registered TB patients. It also upgraded the skills of health professionals, developed infrastructure, improved the quality of TB services, increased awareness of TB among the public and political leaders, and strengthened commitments by central and local governments.

However, several problems remain:

  • Only 30 percent of active cases are detected, leaving many suffering from the disease and able to infect others.
  • Substantial proportions of TB patients do not receive or complete standardised treatment.
  • An increasing proportion of patients have multi-drug resistant (MDR) TB – 7.6 percent among new patients (compared with a global average of 3.2 percent) and as high as 17.1 percent among TB relapse cases.
  • TB control is difficult for rural migrants who work and live in poor conditions in urban areas, who often lack medical insurance and moving frequently.

The researchers identified the possible causes of these problems as:

  • socioeconomic barriers to care seeking, including financial difficulties, social stigma and low awareness of TB as a serious disease
  • ineffectiveness of TB services, particularly in poor areas where inadequately qualified health workers lack necessary medical equipment
  • lack of cooperation between health facilities, often due to financial constraints
  • weak political and financial commitment from local governments.

With substantial support from international organisations and central government, China has an excellent opportunity to build on its successes in TB control. The expansion of DOTS to the whole country should be a top priority. The researchers recommend that those involved in the TB control programme should:

  • develop rational mechanisms to finance all the health facilities responsible for TB control and prevention and provide appropriate incentives for health staff
  • mobilise support from local governments, particularly in poor areas
  • develop proactive approaches to TB case finding, possibly through a community-based surveillance system using trained village health workers
  • develop information, education and communication (IEC) campaigns to increase awareness of the TB epidemic, publicise free services and reduce stigma
  • provide financial support to the poorest patients to cover indirect costs associated with TB treatment
  • use incentives and disciplinary action, if necessary, to improve cooperation between health facilities.

Source(s):
‘What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective’, Health Policy 72: 93-104, by S. Tang and S.B. Squire, 2005
HINARI subscribers can access the full-text article here. Full document.

Funded by: UK Department for International Development

id21 Research Highlight: 27 January 2006

Further Information:
Shenglan Tang
International Health Research Group
Liverpool School of Tropical Medicine
Pembroke Place
Liverpool
L3 5QA
UK

Tel: +44 (0) 151 7053197
Fax: +44 (0) 151 7053364
Contact the contributor: S.Tang@liverpool.ac.uk

Liverpool School of Tropical Medicine (LSTM), UK

Other related links:
'The views of TB control staff on health system decentralisation'

'Tuberculosis control needs strong national health services'

'Changing times - health reform in rural China'

'Fair enough? Access to health services in urban China'

'Better or worse? China’s changing health needs'

'Paying the price? Reforming China’s public health institutions'

'Central reservation? Drawbacks of healthcare decentralisation in China'

Views expressed on these pages are not necessarily those of DFID, IDS, id21 or other contributing institutions. Unless stated otherwise articles may be copied or quoted without restriction, provided id21 and originating author(s) and institution(s) are acknowledged.

Copyright © 2007 id21. All rights reserved.

Week beginning Monday 21st July 2008
FREE Information Delivery services from id21:
Get updates by email: id21 news
Insights: research digests
Contact id21


id21 is funded by the UK Department for International Development www.dfid.gov.uk
id21 is one of a family of knowledge services at the Institute of Development Studies www.ids.ac.uk at the University of Sussex www.sussex.ac.uk
IDS is a charitable company, No. 877338. id21 is a www.oneworld.net partner and an affiliate of
www.mediachannel.org

 

 

Go to the Liverpool School of Tropical Medicine (LSTM), UK site.